Top

Published in:

01-05-2017 | Clinical Study

Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging

Authors: Haiwei Han, Chengkun Han, Xiurong Wu, Shan Zhong, Xiongjie Zhuang, Guowei Tan, Hua Wu

Published in: Journal of Neuro-Oncology | Issue 1/2017

Abstract

The purpose of this study was to determine the difference in discrimination between high- and low-grade supratentorial nonenhancing gliomas (HGGs and LGGs, respectively) when using apparent diffusion coefficient (ADC) values with high or standard b-value. Thirty-nine patients underwent conventional magnetic resonance imaging and diffusion-weighted imaging (DWI) with standard and high b-values (b = 1000 and 3000 s/mm², respectively). Minimum, maximum, and mean ADC values (ADC_MIN, ADC_MAX, and ADC_MEAN, respectively) were measured from ADC maps with both b-values. Receiver operating curve analysis was used to determine the cutoff ADC values for distinguishing between nonenhancing HGGs and LGGs. ADC_MIN, ADC_MAX, and ADC_MEAN values for the nonenhancing HGGs were lower than those for LGGs. These differences were much larger when a high b-value was used (all P < 0.0001) than when a standard b-value was used (P = 0.0001, <0.0001, and <0.0001, respectively). Discriminant analysis indicated that the greatest likelihood for discriminating HGGs and LGGs when ADC_MEAN was obtained with a high b-value, with cutoff value of 0.814 × 10⁻³ mm²/s. ADC values obtained with a high b-value can be useful for grading and surgical management of nonenhancing HGGs and LGGs. The lowest degree of overlap was obtained when ADC_MEAN was determined with a b-value of 3000 s/mm².

Fan GG, Deng QL, Wu ZH, Guo QY (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 79(944):652–658. doi:10.1259/bjr/25349497 CrossRefPubMed

White ML, Zhang Y, Kirby P, Ryken TC (2005) Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? Am J Neuroradiol 26(4):784–790PubMed

Fouke SJ, Benzinger T, Gibson D, Ryken TC, Kalkanis SN, Olson JJ (2015) The role of imaging in the management of adults with diffuse low grade glioma. J Neurooncol 125(11):457–479. doi:10.1007/s11060-015-1908-9 CrossRefPubMed

Lee J, Choi SH, Kim JH, Sohn CH, Lee S, Jeong J (2014) Glioma grading using apparent diffusion coefficient map: application of histogram analysis based on automatic segmentation. NMR Biomed 27(7):1046–1052. doi:10.1002/nbm.3153 CrossRefPubMed

Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, Takaba J, Tominaga A, Hanaya R, Yoshioka H, Hama S, Ito Y, Kajiwara Y, Yahara K, Saito T, Thohar MA (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235(3):985–991. doi:10.1148/radiol.2353031338 CrossRefPubMed

Seo HS, Chang KH, Na DG, Kwon BJ, Lee DH (2008) High b-value diffusion (b = 3000 s/mm²) MR imaging in cerebral gliomas at 3 T: visual and quantitative comparisons with b = 1000 s/mm². Am J Neuroradiol 29(3):458–463. doi:10.3174/ajnr.A0842 CrossRefPubMed

Liu Z, Xiao X (2013) The use of multi b values diffusion-weighted imaging in patients with acute stroke. Neuroradiology 55(3):371–376. doi:10.1007/s00234-012-1129-2 CrossRefPubMed

Watanabe Y, Yamasaki F, Kajiwara Y, Takayasu T, Nosaka R, Akiyama Y, Sugiyama K, Kurisu K (2013) Preoperative histological grading of meningiomas using apparent diffusion coefficient at 3 T MRI. Eur J Radiol 82(4):658–663. doi:10.1016/j.ejrad.2012.11.037 CrossRefPubMed

Cihangiroglu M, Citci B, Kilickesmez O, Firat Z, Karlikaya G, Ulug AM, Bingol CA, Kovanlikaya I (2011) The utility of high b-value DWI in evaluation of ischemic stroke at 3 T. Eur J Radiol 78(1):75–81. doi:10.1016/j.ejrad.2009.10.011 CrossRefPubMed

10.

Purroy F, Begue R, Quilez A, Sanahuja J, Gil MI (2013) Contribution of high-b-value diffusion-weighted imaging in determination of brain ischemia in transient ischemic attack patients. J Neuroimaging 23(1):33–38. doi:10.1111/j.1552-6569.2011.00696.x CrossRefPubMed

11.

Hyare H, Thornton J, Stevens J, Mead S, Rudge P, Collinge J, Yousry TA, Jager HR (2010) High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease. Am J Neuroradiol 31(3):521–526. doi:10.3174/ajnr.A1860 CrossRefPubMed

12.

Riva-Amarante E, Jimenez-Huete A, Toledano R, Calero M, Alvarez-Linera J, Escribano J, Sanchez Migallon MJ, Franch O (2011) Usefulness of high b-value diffusion-weighted MRI in the diagnosis of Creutzfeldt-Jakob disease. Neurologia 26(6):331–336. doi:10.1016/j.nrl.2010.12.003 CrossRefPubMed

13.

Yamasaki F, Kurisu K, Aoki T, Yamanaka M, Kajiwara Y, Watanabe Y, Takayasu T, Akiyama Y, Sugiyama K (2012) Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment. Eur J Radiol 81(10):2805–2810. doi:10.1016/j.ejrad.2011.10.018 CrossRefPubMed

14.

Yoshiura T, Mihara F, Tanaka A, Ogomori K, Ohyagi Y, Taniwaki T, Yamada T, Yamasaki T, Ichimiya A, Kinukawa N, Kuwabara Y, Honda H (2003) High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer’s disease. Neuroimage 20(1):413–419CrossRefPubMed

15.

Han H, Han C, Huang S, Guo J, Zhuang X (2014) Comparison of diffusion-weighted imaging between high and standard b-values for primary central nervous system lymphoma. Clin Radiol 69(9):974–979. doi:10.1016/j.crad.2014.05.002 CrossRefPubMed

16.

Kang Y, Choi SH, Kim YJ, Kim KG, Sohn CH, Kim JH, Yun TJ, Chang KH (2011) Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging–correlation with tumor grade. Radiology 261(3):882–890. doi:10.1148/radiol.11110686 CrossRefPubMed

17.

Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K (2008) Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. Am J Neuroradiol 29(10):1872–1877. doi:10.3174/ajnr.A1254 CrossRefPubMed

18.

Barker FG 2nd, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80(5):936–941CrossRefPubMed

19.

Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59(6):947–949CrossRefPubMed

20.

Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF (1998) The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49(4):436–440CrossRefPubMed

21.

Svolos P, Tsolaki E, Kapsalaki E, Theodorou K, Fountas K, Fezoulidis I, Tsougos I (2013) Investigating brain tumor differentiation with diffusion and perfusion metrics at 3 T MRI using pattern recognition techniques. Magn Reson Imaging 31(9):1567–1577. doi:10.1016/j.mri.2013.06.010 CrossRefPubMed

22.

McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106(4):660–666. doi:10.3171/jns.2007.106.4.660 CrossRefPubMed

23.

Yao Y, Zhou LF (2013) Treatment of incidentally discovered low-grade gliomas: “watch-and-wait” or not? World Neurosurg 80(5):e121–e122. doi:10.1016/j.wneu.2012.10.022 CrossRefPubMed

24.

Shah AH, Madhavan K, Sastry A, Komotar RJ (2013) Managing intracranial incidental findings suggestive of low-grade glioma: learning from experience. World Neurosurg 80(5):e75–e77. doi:10.1016/j.wneu.2012.06.021.CrossRefPubMed

25.

Liu X, Tian W, Kolar B, Yeaney GA, Qiu X, Johnson MD, Ekholm S (2011) MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro Oncol 13(4):447–455. doi:10.1093/neuonc/noq197 CrossRefPubMedPubMedCentral

26.

Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K (1996) Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med 36(6):847–857CrossRefPubMed

27.

Maier SE, Bogner P, Bajzik G, Mamata H, Mamata Y, Repa I, Jolesz FA, Mulkern RV (2001) Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology 219(3):842–849. doi:10.1148/radiology.219.3.r01jn02842 CrossRefPubMed

28.

Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, Takayasu T, Amatya VJ, Akiyama Y, Sugiyama K, Kurisu K (2012) Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T. Eur J Radiol 81(2):339–344. doi:10.1016/j.ejrad.2010.11.005 CrossRefPubMed

29.

DeLano MC, Cooper TG, Siebert JE, Potchen MJ, Kuppusamy K (2000) High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. Am J Neuroradiol 21(10):1830–1836PubMed

30.

Maia AC Jr, Malheiros SM, da Rocha AJ, da Silva CJ, Gabbai AA, Ferraz FA, Stavale JN (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol 26(4):777–783PubMed

31.

Batra A, Tripathi RP, Singh AK (2004) Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australas Radiol 48(3):324–332. doi:10.1111/j.0004-8461.2004.01315.x CrossRefPubMed

32.

Morita N, Wang S, Chawla S, Poptani H, Melhem ER (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32(4):803–808. doi:10.1002/jmri.22324 CrossRefPubMed

33.

Han C, Huang S, Guo J, Zhuang X, Han H (2015) Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases. J Magn Reson Imaging 42:80–86. doi:10.1002/jmri.24747 CrossRefPubMed

34.

Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M (2002) Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44(8):656–666. doi:10.1007/s00234-002-0816-9 CrossRefPubMed

Title: Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging
Authors: Haiwei Han
Chengkun Han
Xiurong Wu
Shan Zhong
Xiongjie Zhuang
Guowei Tan
Hua Wu
Publication date: 01-05-2017
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-017-2423-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT

Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach

Negative prognostic effect of low nuclear GLI1 expression in glioblastomas

Does early resection of presumed low-grade glioma improve survival? A clinical perspective

Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data

The growing role of biology in the treatment of glioblastoma: no more one kind of disease